EA201391605A1 - Способы очистки вирусов с использованием гельпроникающей хроматографии - Google Patents

Способы очистки вирусов с использованием гельпроникающей хроматографии

Info

Publication number
EA201391605A1
EA201391605A1 EA201391605A EA201391605A EA201391605A1 EA 201391605 A1 EA201391605 A1 EA 201391605A1 EA 201391605 A EA201391605 A EA 201391605A EA 201391605 A EA201391605 A EA 201391605A EA 201391605 A1 EA201391605 A1 EA 201391605A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
chromatography
viruses
gelproducting
gel permeation
Prior art date
Application number
EA201391605A
Other languages
English (en)
Russian (ru)
Inventor
Мэттью С. Коффи
Эллисон Хагерман
Роксна Кападиа
Сара Серл
Original Assignee
Онколитикс Байотек Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Онколитикс Байотек Инк. filed Critical Онколитикс Байотек Инк.
Publication of EA201391605A1 publication Critical patent/EA201391605A1/ru

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424Elution mode
    • B01D15/426Specific type of solvent
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12051Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
EA201391605A 2011-04-29 2012-04-27 Способы очистки вирусов с использованием гельпроникающей хроматографии EA201391605A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161480561P 2011-04-29 2011-04-29
PCT/CA2012/000406 WO2012145837A1 (en) 2011-04-29 2012-04-27 Methods of purifying viruses using gel permeation chromatography

Publications (1)

Publication Number Publication Date
EA201391605A1 true EA201391605A1 (ru) 2014-02-28

Family

ID=47067091

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201391605A EA201391605A1 (ru) 2011-04-29 2012-04-27 Способы очистки вирусов с использованием гельпроникающей хроматографии

Country Status (15)

Country Link
US (1) US20120273424A1 (enExample)
EP (1) EP2702147B1 (enExample)
JP (1) JP6029651B2 (enExample)
KR (2) KR20140024406A (enExample)
CN (1) CN103492557B (enExample)
AU (1) AU2012248082B2 (enExample)
CA (1) CA2832367A1 (enExample)
DK (1) DK2702147T3 (enExample)
EA (1) EA201391605A1 (enExample)
ES (1) ES2822199T3 (enExample)
IL (1) IL228491A (enExample)
MX (1) MX337348B (enExample)
SG (1) SG194449A1 (enExample)
TW (1) TW201307561A (enExample)
WO (1) WO2012145837A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2630012T3 (es) 2010-12-02 2017-08-17 Oncolytics Biotech Inc. Formulaciones virales liofilizadas
EA201390810A1 (ru) * 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
BR112015031541A2 (pt) 2013-06-17 2017-07-25 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport métodos para o impedimento da agregação de componentes virais
CN112384615A (zh) 2018-07-04 2021-02-19 普罗拜奥根股份公司 用于纯化包膜病毒的方法
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法
CN114544815B (zh) * 2022-03-01 2023-10-27 中牧实业股份有限公司 一种山羊痘病毒的定量检测方法
CN116718524B (zh) * 2023-06-26 2025-11-07 西安交通大学 一种基于细胞膜色谱技术的病毒颗粒检测方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
ATE148165T1 (de) * 1989-07-24 1997-02-15 Bayer Ag Stabilisierung von hochgereinigten proteinen
BR9507657A (pt) * 1994-05-16 1997-09-09 Merck & Co Inc Proteina isolada e purificada de papilomavirus recombinante capsideos particulas semelhantes a virus processos a virus processos para produzir a proteina para tratar ou prevenir a infecçao por papilomavirus para produzir uma proteina de capsideo de papilomavirus recombinante montada em um capsideo ou particula semelhante a virus e para induzir uma resposta imune em um animal vertebrado composiçoes farmacêuticas kit para a detecçao de papilomavirus ou anticorpos para papilomavirus e sistema sinte
CA2723040A1 (en) * 1998-02-17 1999-08-19 Schering Corporation Compositions comprising viruses and methods for concentrating virus preparations
JP4087712B2 (ja) 2001-03-16 2008-05-21 オンコリティクス バイオテック, インコーポレイティッド 細胞培養物からウイルスを抽出する方法
ATE427990T1 (de) * 2002-04-30 2009-04-15 Oncolytics Biotech Inc Verbesserte reinigungsmethode fur viren
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
EP1878791A1 (en) * 2006-07-11 2008-01-16 Bia Separations D.O.O. Method for influenza virus purification
JP5326155B2 (ja) * 2006-08-07 2013-10-30 一般財団法人化学及血清療法研究所 痘瘡生ワクチンの製造方法
DK2132315T3 (en) * 2007-03-12 2015-10-19 Oncolytics Biotech Inc Reoviruses with modified sequences
CN102089324B (zh) * 2007-11-12 2014-04-16 特罗科隆科学有限公司 用于对流行性感冒进行治疗以及诊断的组合物以及方法
US8227577B2 (en) * 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
EA201390810A1 (ru) * 2010-12-02 2013-09-30 Онколитикс Байотек Инк. Жидкие вирусные составы
ES2630012T3 (es) * 2010-12-02 2017-08-17 Oncolytics Biotech Inc. Formulaciones virales liofilizadas

Also Published As

Publication number Publication date
IL228491A0 (en) 2013-12-31
JP2014516515A (ja) 2014-07-17
CA2832367A1 (en) 2012-11-01
EP2702147B1 (en) 2020-07-15
WO2012145837A1 (en) 2012-11-01
AU2012248082B2 (en) 2015-08-20
US20120273424A1 (en) 2012-11-01
CN103492557A (zh) 2014-01-01
EP2702147A1 (en) 2014-03-05
KR102151890B1 (ko) 2020-09-03
JP6029651B2 (ja) 2016-11-24
MX337348B (es) 2016-02-29
IL228491A (en) 2017-05-29
CN103492557B (zh) 2015-07-29
EP2702147A4 (en) 2014-11-05
KR20190026059A (ko) 2019-03-12
SG194449A1 (en) 2013-12-30
ES2822199T3 (es) 2021-04-29
DK2702147T3 (da) 2020-09-28
AU2012248082A1 (en) 2013-05-09
KR20140024406A (ko) 2014-02-28
MX2013012627A (es) 2014-05-13
TW201307561A (zh) 2013-02-16

Similar Documents

Publication Publication Date Title
EA201391605A1 (ru) Способы очистки вирусов с использованием гельпроникающей хроматографии
MX392274B (es) Cartuchos utiles en limpieza de soluciones de dialisis.
MX2022012089A (es) Anticuerpos que comprenden un dominio de union al antigeno dependiente de la concentracion ionica, variantes de la region fc, anticuerpos de union a interleucina 8 (il-8) y usos de los mismos.
EA201791693A1 (ru) Гетеродимерные иммуноглобулины
SG10201902924RA (en) Antibodies that bind ebola glycoprotein and uses thereof
EA201101593A1 (ru) КОМПОЗИЦИИ И СПОСОБЫ, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ НАПРАВЛЕННОГО ВОЗДЕЙСТВИЯ АНТИТЕЛ НА БЕЛОК С3b СИСТЕМЫ КОМПЛЕМЕНТА
MX358137B (es) Composiciones del polipéptido de fusión tnfr: fc exentas de arginina y métodos de uso.
CU20170039A7 (es) Método de purificación del anticuerpo humanizado 9e4
MX2018000505A (es) Anticuerpos especificos para tau hiperfosforilada y metodos de uso de los mismos.
PH12014500866A1 (en) Immunobinders directed against tnf
EA201291039A1 (ru) Антитела, связывающие cd27 человека, и их применение
EP2691170A4 (en) BIN-FREE ZEOLITIC ADSORPTION AGENTS, METHOD FOR PRODUCING BINDER-FREE ZEOLITIC ADSORPTION AGENTS, AND ADSORPTIVE SEPARATION PROCESSES USING BINDING-FREE ZEOLITE ADSORPTION AGENTS
MX374811B (es) Anticuerpos anti-tau y métodos de uso.
MX2013003182A (es) Purificacion de anticuerpos por cromatografia de lecho movil simulada.
EA201591106A1 (ru) Цеолитовые адсорбенты, способ их изготовления и их применение
EA201591806A1 (ru) Лечение и профилактика острой почечной недостаточности с применением анти-альфа-v-бета-5 антител
MX367661B (es) Anticuerpos anti-baff novedosos.
AU2012249274A8 (en) Neutralizing antibodies to Nipah and Hendra virus
WO2016014434A3 (en) Anti-cd74 antibodies, compositions comprising anti-cd74 antibodies and methods of using anti-cd74 antibodies
EA201591791A1 (ru) Антитела pac1 человека
MX2016001601A (es) Separacion de anticuerpos biespecificos y subproductos de produccion de anticuerpos biespecificos utilizando cromatografia de hidroxiapatita.
EA201301107A1 (ru) Моноклональные антитела против ингибитора пути тканевого фактора (tfpi)
MX379312B (es) Anticuerpos especificos para fcrn.
TN2015000277A1 (en) Bmp-6 antibodies
EA201990593A1 (ru) Непрерывный способ для снижения гетерогенности терапевтического белка